Published in

BMJ Publishing Group, Journal for ImmunoTherapy of Cancer, S2(3), 2015

DOI: 10.1186/2051-1426-3-s2-p203

Links

Tools

Export citation

Search in Google Scholar

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells

Journal article published in 2015 by Chihiro Morishima ORCID, Douglas G. McNeel, Manish R. Patel, Holbrook E. Kohrt, Thomas A. Waldmann, John A. Thompson, Kevin C. Conlon, Paul M. Sondel, Heather A. Wakelee, Minjun C. Apodaca, Steven P. Fling, Mary L. Disis, Stephen P. Creekmore, Jeffrey S. Miller
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

No abstract available.